Methods, systems, and compositions relating to MiRNA-146a
AssigneeHenry Ford Health System
InventorsXianshuang Liu, Zhenggang Zhang, Michael Chopp, Lei Wang, Benjamin A. L. Buller
Life of this patent
Estimating the term…
Loading patent…
AssigneeHenry Ford Health System
InventorsXianshuang Liu, Zhenggang Zhang, Michael Chopp, Lei Wang, Benjamin A. L. Buller
Estimating the term…
Some embodiments comprise methods, systems, and compositions to promote, improve and/or increase neuronal differentiation, oligodendrocyte differentiation, or neurological outcome or function in a patient in need thereof. Some embodiments also comprise the administration a composition comprising a pharmaceutically effective amount of one or more of a group comprising microRNA-146a, exosomes comprising microRNA-146a, a promoter of microRNA-146a expression, a microRNA-146a thymosin beta 4, and a phosphodiesterase 5 inhibitor to treat neurological conditions, diseases, or injuries in mammals, including in human beings.
A method of treating a subject suffering from a neurological disease or injury with exosomes containing miR-146a microRNA, comprising:
A method of treating a subject suffering from a neurological disease or injury with cells capable of producing miR-146a microRNA, the method comprising:
A method of treating a subject suffering from dementia, brain injury, neuropathy, stroke or multiple sclerosis with exosomes containing miR-146a microRNA, the method comprising:
A method of treating a subject suffering from stroke with exosomes containing miR-146a the method comprising:
Dependencies are inferred from the claim text.